These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 34377149)
21. The Journey Through the Pathogenesis and Treatment of Venous Thromboembolism in Inflammatory Bowel Diseases: A Narrative Review. Boccatonda A; Balletta M; Vicari S; Hoxha A; Simioni P; Campello E Semin Thromb Hemost; 2023 Oct; 49(7):744-755. PubMed ID: 36455617 [TBL] [Abstract][Full Text] [Related]
22. Inflammatory bowel disease and atherosclerotic cardiovascular disease in U.S. adults-A population-level analysis in the national health interview survey. Nasir K; Acquah I; Dey AK; Agrawal T; Hassan SZ; Glassner K; Abraham B; Quigley EMM; Blankstein R; Virani SS; Blaha MJ; Valero-Elizondo J; Cainzos-Achirica M; Mehta NN Am J Prev Cardiol; 2022 Mar; 9():100316. PubMed ID: 35112094 [TBL] [Abstract][Full Text] [Related]
23. Low childhood high density lipoprotein cholesterol levels and subsequent risk for chronic inflammatory bowel disease. Voutilainen M; Hutri-Kähönen N; Tossavainen P; Sipponen T; Pitkänen N; Laitinen T; Jokinen E; Rönnemaa T; Viikari JSA; Raitakari OT; Juonala M Dig Liver Dis; 2018 Apr; 50(4):348-352. PubMed ID: 29426615 [TBL] [Abstract][Full Text] [Related]
24. Venous thromboembolism in patients with inflammatory bowel disease: review of literature and practical algorithms. Coremans L; Strubbe B; Peeters H Acta Gastroenterol Belg; 2021; 84(1):79-85. PubMed ID: 33639697 [TBL] [Abstract][Full Text] [Related]
25. Venous thromboembolic events in inflammatory bowel diseases: A review of current evidence and guidance on risk in the post-hospitalization setting. Murthy SK; Robertson McCurdy AB; Carrier M; McCurdy JD Thromb Res; 2020 Oct; 194():26-32. PubMed ID: 32563061 [TBL] [Abstract][Full Text] [Related]
26. Is there a cardiovascular risk in inflammatory bowel diseases? Mitu O; Alexandrescu DM; Cătălina M; Cristina CP Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):918-23. PubMed ID: 25581948 [TBL] [Abstract][Full Text] [Related]
27. The Incidence and Risk Factors of Venous Thromboembolism in Patients with Inflammatory Bowel Disease: A Prospective Multicenter Cohort Study. Ando K; Fujiya M; Nomura Y; Inaba Y; Sugiyama Y; Kobayashi Y; Iwama T; Ijiri M; Takahashi K; Ueno N; Kashima S; Moriichi K; Tanabe H; Mizukami Y; Akasaka K; Fujii S; Yamada S; Nakase H; Okumura T Digestion; 2019; 100(4):229-237. PubMed ID: 30554225 [TBL] [Abstract][Full Text] [Related]
28. Inflammatory bowel disease and cardiovascular diseases: a concise review. Wu H; Hu T; Hao H; Hill MA; Xu C; Liu Z Eur Heart J Open; 2022 Jan; 2(1):oeab029. PubMed ID: 35919661 [TBL] [Abstract][Full Text] [Related]
29. Venous Thromboembolism in Patients with Inflammatory Bowel Disease: The Role of Pharmacological Therapy and Surgery. Papa A; Tursi A; Danese S; Rapaccini G; Gasbarrini A; Papa V J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32635542 [TBL] [Abstract][Full Text] [Related]
30. Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology. Nguyen GC; Bernstein CN; Bitton A; Chan AK; Griffiths AM; Leontiadis GI; Geerts W; Bressler B; Butzner JD; Carrier M; Chande N; Marshall JK; Williams C; Kearon C Gastroenterology; 2014 Mar; 146(3):835-848.e6. PubMed ID: 24462530 [TBL] [Abstract][Full Text] [Related]
32. Prevention and therapeutic strategies of thromboembolic events in patients with inflammatory bowel diseases: a report of three cases. Włodarczyk M; Sobolewska A; Fichna J; Wiśniewska-Jarosińska M Curr Drug Targets; 2015; 16(3):194-8. PubMed ID: 25382207 [TBL] [Abstract][Full Text] [Related]
33. Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol: the Korea Medical Insurance Corporation Study. Jee SH; Suh I; Kim IS; Appel LJ JAMA; 1999 Dec; 282(22):2149-55. PubMed ID: 10591337 [TBL] [Abstract][Full Text] [Related]
34. Comparison of a novel predictor of venous thromboembolic complications in inflammatory bowel disease with current predictors. Ohta Y; Arai M; Nakagawa T; Akizue N; Ishikawa K; Hamanaka S; Koseki H; Taida T; Okimoto K; Saito K; Yoshihama S; Maruoka D; Matsumura T; Katsuno T; Kato N J Gastroenterol Hepatol; 2019 May; 34(5):870-879. PubMed ID: 30225931 [TBL] [Abstract][Full Text] [Related]
35. An overview of lipid abnormalities in patients with inflammatory bowel disease. Agouridis AP; Elisaf M; Milionis HJ Ann Gastroenterol; 2011; 24(3):181-187. PubMed ID: 24713706 [TBL] [Abstract][Full Text] [Related]
37. Hormonal contraceptives and venous thromboembolism: Are inflammatory bowel disease patients at increased risk? A retrospective study on a prospective database. Pellino G; Sciaudone G; Caprio F; Candilio G; De Fatico GS; Reginelli A; Canonico S; Selvaggi F Ann Med Surg (Lond); 2015 Dec; 4(4):462-6. PubMed ID: 26779335 [TBL] [Abstract][Full Text] [Related]
38. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study. Bernstein CN; Wajda A; Blanchard JF Clin Gastroenterol Hepatol; 2008 Jan; 6(1):41-5. PubMed ID: 18063423 [TBL] [Abstract][Full Text] [Related]
39. The epidemiology of inflammatory bowel disease. Burisch J; Munkholm P Scand J Gastroenterol; 2015 Aug; 50(8):942-51. PubMed ID: 25687629 [TBL] [Abstract][Full Text] [Related]